JFS Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.2K | Buy |
27
+1
| +4% | +$526 | ﹤0.01% | 750 |
|
|
2025
Q1 | $16.5K | Sell |
26
-1
| -4% | -$634 | ﹤0.01% | 721 |
|
|
2024
Q4 | $19.2K | Sell |
27
-6
| -18% | -$4.27K | ﹤0.01% | 657 |
|
|
2024
Q3 | $34.7K | Buy |
33
+1
| +3% | +$1.05K | ﹤0.01% | 528 |
|
|
2024
Q2 | $33.6K | Sell |
32
-2
| -6% | -$2.1K | ﹤0.01% | 485 |
|
|
2024
Q1 | $32.7K | Hold |
34
| – | – | ﹤0.01% | 517 |
|
|
2023
Q4 | $29.9K | Hold |
34
| – | – | ﹤0.01% | 499 |
|
|
2023
Q3 | $28K | Hold |
34
| – | – | ﹤0.01% | 470 |
|
|
2023
Q2 | $24.4K | Sell |
34
-2
| -6% | -$1.44K | ﹤0.01% | 496 |
|
|
2023
Q1 | $29.6K | Sell |
36
-2
| -5% | -$1.64K | ﹤0.01% | 449 |
|
|
2022
Q4 | $27.4K | Buy |
38
+1
| +3% | +$722 | ﹤0.01% | 466 |
|
|
2022
Q3 | $25K | Buy |
37
+12
| +48% | +$8.11K | ﹤0.01% | 521 |
|
|
2022
Q2 | $15K | Sell |
25
-1
| -4% | -$600 | ﹤0.01% | 652 |
|
|
2022
Q1 | $18K | Buy |
26
+17
| +189% | +$11.8K | ﹤0.01% | 635 |
|
|
2021
Q4 | $6K | Buy |
+9
| New | +$6K | ﹤0.01% | 767 |
|
|
2016
Q2 | – | Sell |
-1
| Closed | – | – | 597 |
|
|
2016
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 656 |
|